Prediction Market Signals Potential US Government Stakes in IonQ Micron and Anduril Canadas Big Banks Expected to Report Solid Q2 Earnings but Outlook Takes Center Stage Amid Softening Economy Judge Dismisses Criminal Case Against Wrongfully Deported Maryland Man Raising Questions on Immigration Enforcement Understanding Offer for Sale OFS A Key Mechanism for Shareholders to Exit FTSE Russell to Accelerate Inclusion of US MegaIPOs in Indexes US Stock Markets Rally SP 500 Records Longest Winning Streak Since 2023 Dow Gains Over 2 AREC Q3 2025 Earnings NarrowerthanExpected Loss Drives Positive Sentiment Akari Therapeutics Q1 2026 Earnings EPS Miss Amid No Revenue Stock Surges 515 TaskUs Inc TASK Q1 2026 Earnings Small EPS Miss on Modest Revenue Uncertainty KRMD Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline KUST Q4 2025 Earnings Deep EPS Miss Raises Concerns Amid Unreported Revenue Affiliated Managers Group Inc AMG Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher TMobile US Senior Notes TMUSI Edge Higher Yield Considerations and Key Levels Sixth Street Specialty Lending TSLX Retreats from Recent Highs Key Levels to Watch Vox Royalty Corp VOXR Advances 505 as Bullish Momentum Builds ABVC BioPharma Inc ABVC Edges Higher After Recent Pullback Testing Key Resistance Level TWLV Holds Steady at 995 SPAC Consolidation Signals Potential for Breakout Federal Reserve Rate Cut Hopes Dim as April Jobs Data Reinforces Inflation Focus ADC Therapeutics Q1 2026 Earnings EPS Beat but No Revenue Reported Stock Slips Jazz Pharmaceuticals JAZZ Modestly Advances as Traders Eye Key Resistance Zone Blackrock Enhanced Global Dividend Trust BOE Holds Near Support Amid Modest Decline abrdn National Municipal Income Fund VFL Edges Higher as Price Nears Resistance Aveanna Healthcare Holdings AVAH Dips 443 Support Levels in Focus After Recent Decline Canadian Natural Resources CNQ Slips 22 as Energy Sector Faces Selling Pressure Ernexa Therapeutics ERNA Slides 25 as Weakness Persists Near Support Levels Preformed Line Products PLPC Surges 39 as Momentum Builds Toward Key Resistance Tectonic Therapeutic TECX Retreats 22 as Stock Tests Key Support Levels